<Disease><Name>ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY (AMACRD)</Name><Synonym>AMACR DEFICIENCY</Synonym><OMIM><Number>614307</Number><URL>http://omim.org/entry/614307</URL></OMIM><Orphanet><Number>79095</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79095</URL></Orphanet><Protein><Number>alpha-methylacyl-CoA racemase</Number><URL>http://www.uniprot.org/uniprot/Q9UHK6</URL></Protein><ExPASy><Number>5.1.99.4</Number><URL>http://enzyme.expasy.org/EC/5.1.99.4</URL></ExPASy><Gene>5p13.2</Gene><ICD>K76.8</ICD><Summary>very rare (&gt;5 cases) ;autosomal recessive ;mutation in the AMACR gene&#160; ;Inborn errors of bile acid metabolism may present as neonatal cholestasis and fat-soluble vitamin malabsorption or as late onset chronic liver disease [Setchell et al. 2003]</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2257</id><symptom>cholestasis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2000</id><symptom>gallstones, cholelithiasis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3978</id><symptom>giant cell hepatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1925</id><symptom>headache (severe, recurrent or occipital, migraine)</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2468</id><symptom>impaired visual acuity</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3369</id><symptom>neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1972</id><symptom>paraparesis/paraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4016</id><symptom>paresis</symptom><category>MUSCLES</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp><symtomp><id>2375</id><symptom>retinopathy</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>3967</id><symptom>status epilepticus</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>884</id><name>Dihydroxycholestanoic acid (DHCA)</name><specimen>cerebrospinal fluid</specimen><value /><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>885</id><name>Dihydroxycholestanoic acid (DHCA)</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.12</max><unit>&#181;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1041</id><name>Phosphatase, alkaline</name><specimen>serum</specimen><value>increased</value><min>60.00</min><max>170.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1042</id><name>Phosphatase, alkaline</name><specimen>serum</specimen><value>increased</value><min>20.00</min><max>150.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>436</id><name>Phytanic acid</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>3.10</max><unit>&#956;g/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>500</id><name>Phytanic acid</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>4.00</max><unit>&#956;g/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>881</id><name>Phytanic acid</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>0.00</min><max>4.00</max><unit>&#956;g/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>792</id><name>Pristanic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>&#181;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>880</id><name>Pristanic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>1.00</max><unit>nmol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>886</id><name>Trihydroxycholestanoic acid (THCA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>child</age><method /><comment /></metabolite><metabolite><id>887</id><name>Trihydroxycholestanoic acid (THCA)</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.03</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>3605</id><title>MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing</title><author>Haugarvoll K,</author><journal>Orphanet J Rare Dis</journal><year>2013</year><book /><volume>8</volume><number>0</number><pages>1</pages><co_aut>et al.</co_aut></literature><literature><id>3606</id><title>AMACR mutations cause late-onset autosomal recessive cerebellar ataxia</title><author>Dick D,</author><journal>Neurology</journal><year>2011</year><book /><volume>76</volume><number>20</number><pages>1768-1770</pages><co_aut>Horvath R, Chinnery PF</co_aut></literature><literature><id>3604</id><title>An adult onset case of alpha-methyl-acyl-CoA racemase deficiency</title><author>Smith EH,</author><journal>J Inherit Metab Dis Suppl 3</journal><year>2010</year><book /><volume>0</volume><number>0</number><pages>S349-S353</pages><co_aut>et al.</co_aut></literature><literature><id>2910</id><title>Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency</title><author>Thompson SA</author><journal>J Neurol Neurosurg Psychiatry</journal><year>2008</year><book /><volume>79</volume><number>4</number><pages>448-450</pages><co_aut>et al.</co_aut></literature><literature><id>2911</id><title>Mechanisms of disease: Inborn errors of bile acid synthesis</title><author>Sundaram SS</author><journal>Nat Clin Pract Gastroenterol Hepatol</journal><year>2008</year><book /><volume>5</volume><number>8</number><pages>2008</pages><co_aut>et al.</co_aut></literature><literature><id>1983</id><title>Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency</title><author>Clarke CE</author><journal>Neurology</journal><year>2004</year><book /><volume>63</volume><number>1</number><pages>188-189</pages><co_aut>et al.</co_aut></literature><literature><id>1985</id><title>A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl</title><author>Savolainen K</author><journal>Hum Mol Genet</journal><year>2004</year><book /><volume>13</volume><number>9</number><pages>955965</pages><co_aut>et al.</co_aut></literature><literature><id>1984</id><title>Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy</title><author>Setchell KD</author><journal>Gastroenterology</journal><year>2003</year><book /><volume>124</volume><number>1</number><pages>217-232</pages><co_aut>et al.</co_aut></literature><literature><id>1986</id><title>A new defect of peroxisomal function involving pristanic acid: a case report</title><author>McLean BN</author><journal>J Neurol Neurosurg Psychiatry</journal><year>2002</year><book /><volume>72</volume><number>3</number><pages>396-399</pages><co_aut>et al.</co_aut></literature><literature><id>1981</id><title>Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal alpha-methylacyl-CoA racemase deficiency</title><author>Ferdinandusse S</author><journal>J Lipid Res</journal><year>2001</year><book /><volume>42</volume><number>1</number><pages>137-141</pages><co_aut>et al.</co_aut></literature><literature><id>1982</id><title>Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase defic</title><author>Van Veldhoven PP</author><journal>Eur J Clin Invest</journal><year>2001</year><book /><volume>31</volume><number>8</number><pages>714-722</pages><co_aut>et al.</co_aut></literature><literature><id>1980</id><title>Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy</title><author>Ferdinandusse S</author><journal>Nat Genet</journal><year>2000</year><book /><volume>24</volume><number>2</number><pages>188-191</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>